Cardiac Insight, Inc. to Present at the 147th National Investment Banking Association Conference Slated for November 12-13, 2019 in New York City

BELLEVUE, WA / ACCESSWIRE / November 7, 2019 / Cardiac Insight, Inc. announced today that the Company’s CEO is scheduled to present at the 147th National Investment Banking Association (NIBA) conference scheduled for November 12-13, 2019 at the Westin Times Square Hotel in New York City. Brad Harlow, Chief Executive Officer, will be presenting Wednesday, November 13th, as well as meeting with investors.

For more information about NIBA or participating in our upcoming New York Conference on November 12th-13th, 2019 please visit www.nibanet.org or contact us at emily@nibanet.org or 706-208-9620.

About Cardiac Insight, Inc.

Cardiac Insight, Inc., headquartered in Bellevue, WA, USA, is a leading US developer of advanced body-worn digital healthcare systems that leverage its proprietary, automated cardiac analysis software, ECG algorithms and wearable ECG sensors. With decades of combined expertise in spearheading diagnostic solutions, our team of medical, technology and healthcare experts is singly focused on developing innovative, patented technologies for the early detection and advanced study of cardiac arrhythmias including atrial fibrillation, long QT syndrome and other high-risk disease states.

Cardiac Insight’s highly-differentiated customer-facing solutions eliminate costly and time-consuming outsourced third-party ECG services, and are uniquely designed to enhance clinical efficacy to the benefit of patients, physicians and researchers. Our solutions deliver immediate and complete access to data and advanced research analytics with the goal to shorten mean time to cardiac diagnosis and treatment.

About National Investment Banking Association (NIBA)

Since 1982, the National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. We have hosted 146 investment conferences showcasing hundreds of public and private companies seeking access to the financial industry. Our network has raised over $17 billion and is responsible for 90% of all IPOs under $20 million. Our network is made up of thousands of investment professionals representing over 60 key industry services and includes over 8,800 registered representatives that have over $78 billion in assets under management.

Additional details about the National Investment Banking Association’s 147th Investment Conference, Nov. 12-13, 2019, in New York City can be found at: https://nibanet.org/conferences/niba-november-12-13-2019-new-york-ny-conference.

Contact:

Brad Harlow, CEO
Cardiac Insight, Inc.
Email: bharlow@cardiacinsightinc.com
Main: (206) 596-2060
Direct: (206) 596-2061

SOURCE: Cardiac Insight, Inc.

View source version on accesswire.com:
https://www.accesswire.com/565653/Cardiac-Insight-Inc-to-Present-at-the-147th-National-Investment-Banking-Association-Conference-Slated-for-November-12-13-2019-in-New-York-City

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

13 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

16 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

16 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

16 hours ago